Cannabidiol in Opioid Use Disorder and Chronic Pain

NCT04587791 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Chronic Pain
Opioid Use Disorder

Interventions

DRUG: 400 mg Cannabidiol
DRUG: 800 mg Cannabidiol
DRUG: 1200 mg Cannabidiol
DRUG: Beta carotene oral solution without CBD

Sponsor

Yale University

Collaborators

[object Object]
[object Object]